The Healthcare Businesswomen’s Association has named Beth Seidenberg of Westlake Village BioPartners as its 2022 Woman of the Year. She will be feted live and virtually at the HBA’s annual conference in New York City on May 10. Seidenberg “has medicine in her blood,” a statement from the association says, noting that as a researcher Read More →
Capsida Biotherapeutics, a venture-backed Thousand Oaks company developing gene therapy treatments, announced the hiring of a new CEO on Dec. 7. In April, Capsida emerged from “stealth mode” and closed a $140 million series A funding round, one of the largest venture capital raises of the year in the region’s life sciences sector. Capsida is Read More →
Capsida Biotherapeutics, a biotechnology startup based in Thousand Oaks, announced April 29 that it is emerging from “stealth mode” with a $140 million funding round led by Westlake Village BioPartners and Versant Ventures. The Series A round includes $50 million from Westlake Village BioPartners, a venture capital firm in Thousand Oaks focused on biotech startups Read More →
Westlake Village BioPartners has launched two new funds worth a total of $500 million, bringing the total raised by the firm to more than $820 million since it was founded in 2018.
Westlake Village BioPartners, a venture capital firm focused on biotech startups in the Conejo Valley and the rest of greater Los Angeles, launched two new funds Dec. 15 worth a total of $500 million. The first fund is $70 million and will be used for Series B or later financing into companies that Westlake Village Read More →